Alzheimer’s disease (AD) presents ongoing challenges for sponsors seeking earlier identification and more efficient therapeutic evaluation. Join experts from across IQVIA as they share the latest advances in AD clinical research. From early patient identification to leveraging breakthrough biomarkers and global site networks, the featured speakers will discuss actionable strategies for optimizing central nervous system (CNS) trials.
Discover how innovative approaches and operational expertise can help biotech and emerging biopharma sponsors lead therapeutic innovation, accelerate recruitment, overcome trial challenges and stay ahead in a rapidly evolving market.
Register for this webinar to learn how Alzheimer’s disease trial strategies can improve design, recruitment and decision-making.
Speakers
Joanna Pulawska, PhD, Therapeutic Area Head, CNS, IQVIA Biotech
Joanna Pulawska oversees Global Operations and Strategic Delivery for clinical trials in CNS and CVRM therapeutic areas at IQVIA Biotech. With over 20 years of experience in global clinical research, she has held senior leadership roles across therapeutic areas, including oncology, neurology, immunology and cardiovascular diseases. Joanna earned her PhD in Molecular Biology from the University of Toronto and holds an MSc from the University of Warsaw.
Message Presenter
Marek Bieniek, MD, Senior Director, Medical Strategy, CNS Center of Excellence, IQVIA
Dr. Marek Bieniek is a board-certified Neurologist with over 25 years of experience in neurology practice and more than 10 years in Medical Affairs in the pharmaceutical industry. His research focuses on MRI imaging in understanding MS pathology. At IQVIA’s CNS Center of Excellence, he supports the development of innovative therapies for neurological disorders.
Message Presenter
Anu Chaudhary, PhD, Director, Global Lead Immunology, IQVIA Laboratories
Anu Chaudhary, PhD, is the Global Technical Lead for Immunology at IQVIA Laboratories, overseeing assay development and execution for clinical testing. With over 28 years of experience in research, assay development and drug discovery, Anu holds a PhD from SUNY-Stony Brook and completed postdoctoral studies at Harvard Medical School and Fred Hutchinson Cancer Research Center. Her career spans roles in the pharmaceutical industry, Los Alamos National Laboratory and the University of Washington School of Medicine.
Message Presenter
Who Should Attend?
This webinar is intended for C-suite and clinical development/operations executives in small, mid and large pharma and biotech companies.
What You Will Learn
Attendees will gain insight into:
- The impacts of biomarkers and diagnostics for earlier, more precise detection
- Best practices in patient recruitment, site management and global trial execution for operational excellence
- Novel trial designs and patient identification, transforming early intervention strategies in Alzheimer’s research for biotech
Xtalks Partner
IQVIA Biotech
IQVIA Biotech is a biotech-specialized CRO delivering flexible clinical development solutions for biotech and emerging biopharma companies. Our clinical solutions are built on 25+ years of unmatched experience with therapeutically aligned expertise, uniquely designed to deliver full-service solutions on a global scale. Learn more at iqviabiotech.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account